Skip to Main Content

Paper Details

A correlative biomarker study and integrative prognostic model in chemotherapy-naïve metastatic castration-resistant prostate cancer treated with enzalutamide.
Prostate
2
2023
Author NameAffiliation
Emmanuel S AntonarakisJohns Hopkins University School of Medicine
Gerhardt AttardUniversity College London Cancer Institute
  • 1 - 2

Datasets

Release 1.2